|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.290 USD | +2.03% |
|
-11.10% | +19.10% |
| Market Cap | 2.36B 2.06B 1.9B 1.76B 3.31B 227B 3.38B 22.76B 8.95B 111B 8.87B 8.67B 383B | P/E 2026 * |
-3.6x | P/E 2027 * | 14.8x |
|---|---|---|---|---|---|
| Enterprise Value | 2.44B 2.13B 1.97B 1.82B 3.42B 235B 3.5B 23.54B 9.26B 115B 9.17B 8.97B 397B | EV / Sales 2026 * |
3.65x | EV / Sales 2027 * | 3x |
| Free-Float |
94.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioCryst Pharmaceuticals, Inc.
| 1 day | +2.03% | ||
| 1 week | -11.10% | ||
| Current month | -7.10% | ||
| 1 month | +3.34% | ||
| 3 months | -2.21% | ||
| 6 months | +39.49% | ||
| Current year | +19.10% |
| 1 week | 8.95 |  | 10.23 |
| 1 month | 8.91 | | 11.22 |
| Current year | 6.23 | | 11.22 |
| 1 year | 6 | | 11.22 |
| 3 years | 4.03 | | 11.31 |
| 5 years | 4.03 | | 19.99 |
| 10 years | 1.38 | | 19.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Gayer
CEO | Chief Executive Officer | 55 | 01/01/2026 |
Babar Ghias
DFI | Director of Finance/CFO | 47 | 07/07/2025 |
Sandeep Menon
CTO | Chief Tech/Sci/R&D Officer | 51 | 06/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Stonehouse
BRD | Director/Board Member | 65 | 01/01/2007 |
Theresa Heggie
BRD | Director/Board Member | 64 | 03/12/2018 |
Charles Gayer
BRD | Director/Board Member | 55 | 01/01/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/6/26 | Free | Director | 48,834 | 0.0192% | ||
| 11/6/26 | Free | Director | 48,834 | 0.0192% | ||
| 11/6/26 | Free | Director | 48,834 | 0.0192% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.03% | -11.10% | +7.90% | +29.57% | 2.36B | |
| +0.24% | -1.54% | +52.85% | +71.85% | 53.83B | |
| -7.17% | -4.39% | +42.72% | +73.32% | 52.1B | |
| +0.80% | -6.31% | +5.62% | +417.78% | 23.48B | |
| -0.09% | -0.01% | -16.85% | -15.41% | 23.13B | |
| -5.95% | -2.58% | +29.53% | -9.47% | 19.36B | |
| -1.14% | +0.03% | +31.67% | -30.65% | 17.56B | |
| -5.16% | -7.00% | +168.44% | +314.96% | 15.2B | |
| -6.91% | -5.83% | +25.17% | +644.30% | 14.83B | |
| +0.43% | -1.03% | +25.75% | +189.74% | 14.06B | |
| Average | -2.29% | -3.47% | +37.28% | +168.60% | 23.59B | |
| Weighted average by Cap. | -2.75% | -2.44% | +39.23% | +141.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 669M 585M 539M 497M 937M 64.41B 958M 6.45B 2.54B 31.55B 2.51B 2.46B 109B | 726M 634M 585M 539M 1.02B 69.88B 1.04B 6.99B 2.75B 34.23B 2.73B 2.67B 118B |
| Net income | -641M -560M -517M -477M -898M -61.74B -918M -6.18B -2.43B -30.24B -2.41B -2.35B -104B | 155M 135M 125M 115M 217M 14.88B 221M 1.49B 586M 7.29B 580M 568M 25.09B |
| Net Debt | 80.91M 70.71M 65.25M 60.14M 113M 7.79B 116M 780M 307M 3.82B 304M 297M 13.14B | -181M -158M -146M -134M -253M -17.4B -259M -1.74B -685M -8.52B -678M -664M -29.33B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | US$9.290 | +2.03% | 3,272,762 |
| 16/07/26 | US$9.105 | -3.24% | 3,561,547 |
| 15/07/26 | US$9.410 | -3.39% | 6,813,775 |
| 14/07/26 | US$9.740 | -1.72% | 3,968,215 |
| 13/07/26 | US$9.910 | -5.17% | 3,147,935 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BCRX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
